Vexim SpineJack and Masterflow registered in Australia for vertebral fracture treatment

337

Vexim logoVexim has received regulatory approval from the Therapeutic Goods Administration to commercialise its SpineJack and the cement delivery system, Masterflow, in Australia.

According to a press release, the company is expanding its international presence whilst preparing  the development of new products.

Vincent Gardès, Vexim’s chief executive officer, concludes, “This registration will enable us to have a substantial increase of our global activities. The company considers launching the exportation in Australia by the end of 2016.”